Kinapse provides expert advisory, capability building and operational services to the world’s leading life sciences organisations, their customers, suppliers and regulators with a particular focus on the areas of regulatory and compliance. It counts nine of the world’s top ten pharma companies and regulatory organisations as its customers; these include Pfizer, GSK, Merck Serono, Johnson & Johnson and the European Medicines Agency.
Backed by Synova Capital and based in Wimbledon, Kinapse currently employs more than 500 people in the UK, US and India, with a model that brings together people in virtual teams across a wide range of R&D domains.
Its average international growth rate over the past two years is a whopping 76 per cent, putting the firm 28th in the 2015 Sunday Times Fast Track SME Export 100. It has also featured in the Sunday Times Fast Track 100 as the fastest growing life science company in the UK for three consecutive years in 2013, 2014 and 2015. It has also been identified by the London Stock Exchange as one of the 1000 Companies to Inspire Britain.”
For more information please visit www.kinapse.com